India to Canada: Ramipril Export Trade Route

The India to Canada Ramipril corridor is one of India's established pharmaceutical export routes, with 514 shipments documented worth a combined $5.6M USD. The route is dominated by APOTEX RESEARCH PRIVATE LIMITED, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's ramipril manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $10.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with ramipril's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 27.4%, placing it at rank #7 among India's top ramipril export destinations globally.

On the import side, key buyers of Indian ramipril in Canada include APOTEX INC,, SUN PHARMA CANADA INC, APOTEX INC and 28 others. APOTEX INC, is the single largest importer with 45 shipments valued at $1.8M USD.

India's ramipril exports to Canada are driven primarily by a handful of large-scale manufacturers. APOTEX RESEARCH PRIVATE LIMITED with 65 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — APOTEX RESEARCH PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, IPCA LABORATORIES LIMITED — together account for 78% of total trade value on this route. The average shipment value of $10.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as apo-ramipril cap 10mg 500 btl 47490 / 771313171366-vj6697 and harmless medicines pharma-ramipril ra, suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, APOTEX INC, is the largest importer with 45 shipments worth $1.8M USD — representing 33% of all ramipril imports from India on this route. A total of 31 buyers are active on this corridor.